Photo from wikipedia
Patients with chronic hepatitis C (CHC) have an increased risk of atherosclerotic cardiovascular disease which may be due to inflammation and endothelial dysfunction caused by the chronic infection. In this… Click to show full abstract
Patients with chronic hepatitis C (CHC) have an increased risk of atherosclerotic cardiovascular disease which may be due to inflammation and endothelial dysfunction caused by the chronic infection. In this prospective pilot study, we assessed, for the first time among patients with CHC the myocardial perfusion reserve (MPR) by Rubidium‐82 (82Rb) positron emission tomography (PET)/computed tomography (CT) before and after direct‐acting antiviral (DAA) treatment and compared them with biomarkers of systemic inflammation and endothelial dysfunction.
Journal Title: Clinical Physiology and Functional Imaging
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!